Davita Healthcare Partners, Inc. (NYSE:DVA)

CAPS Rating: 4 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

1
Player Avatar Smiley81 (< 20) Submitted: 4/29/2008 10:35:47 AM : Outperform Start Price: $25.26 DVA Score: +135.20

$60+/share

Featured Broker Partners


Advertisement